Mid-Year Report
THE LIVINGSTON GROUP, LLC for PKD FOUNDATION
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 (HR 3282) HHS, Defense Appropriations for research and clinical funding for PKD (HR 3043, S 1710; HR 3222); Genetic Information Nondiscrimination Legislation (HR 493; S 358); National PKD Awareness Week Resolution (S. Res. 282);
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT L LIVINGSTON | N/A |
| J ALLEN MARTIN | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.